DDrare: Database of Drug Development for Rare Diseases

Searched query = "Wolfram syndrome", "Diabetes Insipidus, Diabetes mellitus, optic atrophy, and deafness syndrome", "DIDMOAD syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Drug = Acetylcysteine; Dantrolene; Dantrolene sodium; Deferiprone; Exenatide; Metformin; Sitagliptin; Sitagliptin and Metformin; Sodium Valproate 200Mg E/C Tablet; Sodium Valproate Wockhardt 200mg Gastro-Resistant tablets; Sodium valproate 200 mg gastro-resistant tablets; Valproate

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01302327 (ClinicalTrials.gov)	March 2011	22/2/2011	GLP Analogs for Diabetes in Wolfram Syndrome Patients		Diabetes Mellitus Associated With Genetic Syndrome;Wolfram Syndrome	Drug: Exenatide	Hadassah Medical Organization	NULL	Not yet recruiting	18 Years	N/A	Both	10	N/A	NULL

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

NCT01302327
(ClinicalTrials.gov)

March 2011

22/2/2011

GLP Analogs for Diabetes in Wolfram Syndrome Patients

Diabetes Mellitus Associated With Genetic Syndrome;Wolfram Syndrome

Drug: Exenatide

Hadassah Medical Organization

NULL

Not yet recruiting

18 Years

N/A

Both

N/A

NULL